Stevanato group will introduce its large-volume vertiva® 10ml on-body delivery system platform for injectable therapies at cphi milan

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, announced today the expansion of its vertiva® platform, which will include a 10ml option to be presented at cphi milan in october. the vertiva® easy-to-use platform can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-c.
STVN Ratings Summary
STVN Quant Ranking